7 unchanged sentences
Purchase of Equity Securities by the Issuer
−Removed: In December 2021, our Board of Directors authorized a capital return program to repurchase up to $750.0 million of our outstanding common stock over a three-year period.
−Removed: During 2021, we repurchased 3.9 million shares of common stock for $150.0 million at an average price of $38.51.
−Removed: During 2022, we repurchased 4.5 million shares of common stock for $200.0 million at an average price of $44.44.
−Removed: During 2023, excluding the shares we received in the Accelerated Share Repurchase (“ASR”), we repurchased 4.2 million shares of common stock for $150.0 million at an average price of $36.01.
−Removed: We repurchased a total of 12.6 million shares for $500.0 million at an average price per share of $39.81 excluding the 5.5 million shares we received under the ASR in November 2023.
−Removed: We accelerated the initiation of our planned 2024 share repurchases and in November 2023, we entered into an ASR agreement with Bank of America to accelerate the remaining $250.0 million of share repurchases under the approved capital return program.
−Removed: Pursuant to the agreement, at the inception of the ASR, we paid $250.0 million to Bank of America and took initial delivery of 5.5 million shares.
+Added: In December 2021, our Board of Directors authorized a capital return program to repurchase up to $750.0 million of our outstanding common stock over a three-year period which we completed in June 2024.
+Added: A total of 19.1 million shares were repurchased over the three-year period at an average price per share of $39.31.
+Added: All shares repurchased under our capital return programs have been retired and have resumed their status of authorized and unissued shares.
In February 2024, our Board of Directors authorized a new capital return program to repurchase up to $750.0 million of our outstanding common stock.
+Added: In December 2024, we entered into an Accelerated Share Repurchase (“ASR”) agreement with
+Added: Bank of America to repurchase $250.0 million of our common stock.
+Added: Pursuant to the agreement, at the inception of the ASR,
+Added: we paid $250.0 million to Bank of America and took initial delivery of 4.2 million shares, representing approximately 80 percent of the total shares that will be repurchased under the ASR agreement measured based on the closing price of our common stock on the transaction trade date.
+Added: The final share count will be determined at the transaction settlement date.
+Added: All shares repurchased under our capital return programs have been retired and have resumed their status of authorized and unissued shares.
+Added: The table below sets forth information regarding repurchases during the three months ended December 31, 2024:
+Added: Period Total Number of Shares Purchased Weighted-Average Price paid per share Total Number of Shares Purchased as Part of Publicly Announced Programs Approximate Dollar Value of Shares That May Yet Be purchased under the Programs (thousands)
+Added: October 1, 2024 through October 31, 2024
+Added: — $ — — $ 750,000
+Added: November 1, 2024 through November 30, 2024
+Added: — $ — — $ 750,000
+Added: December 1, 2024 through December 31, 2024 (1)
+Added: 4,181,476 $ — 4,181,476 $ 500,000
+Added: Total 4,181,476 4,181,476
+Added: (1) Purchased under the share repurchase program authorized in February 2024.
+Added: The shares are purchased through an ASR agreement to repurchase $250.0 million of common stock.
+Added: In December 2024, we took initial delivery of 4.2 million shares, representing approximately 80 percent of the total shares that will be repurchased under the ASR agreement measured based on the closing price of our common stock on the transaction trade date.
+Added: The final share count will be determined at settlement date.
Stock Performance Graph and Cumulative Total Return
3 unchanged sentences
The historical stock price performance included in this graph is not necessarily indicative of future stock price performance.
+Added: COMPARISON OF CUMULATIVE TOTAL RETURN FROM
+Added: 12/31/2019 THROUGH 12/31/2024
+Added: Among Halozyme Therapeutics, Inc., The NASDAQ Composite Index
+Added: and The NASDAQ Biotechnology Index
+Added: *$100 invested on 12/31/2019 in stock or index, including reinvestment of dividends.
12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.